Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids
|
June 27, 2024
DNA-Templated Nanofabrication of CdS-Au Nanoscale Schottky Contacts and Electrical Characterization
Chao Pang, Benjamin T Karlinsey, Megan Ward, et al.
Cancer Investigation
|
October 3, 2013
Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature
Brent D Van Rite, John J Krais, Mohamad Cherry, et al.
Journal of Nanoscience and Nanotechnology
|
October 28, 2015
Optical and Magnetic Properties of ZnO Nanoparticles Doped with Co, Ni and Mn and Synthesized at Low Temperature
Jared M Hancock, William M Rankin, Talaat M Hammad, et al.
Biophysical Journal
|
November 28, 2020
Mechanism and Kinetics of Copper Complexes Binding to the Influenza A M2 S31N and S31N/G34E Channels
Kelly L McGuire, Phillip Smit, Daniel H Ess, et al.
Anticancer Research
|
July 11, 2006
Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration
Xiao-Ping Zang, Naveen R Palwai, Megan R Lerner, et al.
Nanotechnology
|
August 27, 2013
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy
Luís F F Neves, John J Krais, Brent D Van Rite, et al.
Molecular Biomedicine
|
February 18, 2024
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, et al.
Blood
|
October 1, 2005
A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties
Xin Huang, Wei-Qun Ding, Joshua L Vaught, et al.
Molecular Biomedicine
|
April 2, 2024
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, et al.
Molecular Cancer Therapeutics
|
May 20, 2017
Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide
John J Krais, Needa Virani, Patrick H McKernan, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Langmuir : the ACS Journal of Surfaces and Colloids
|
June 27, 2024
DNA-Templated Nanofabrication of CdS-Au Nanoscale Schottky Contacts and Electrical Characterization
Chao Pang, Benjamin T Karlinsey, Megan Ward, et al.
Cancer Investigation
|
October 3, 2013
Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature
Brent D Van Rite, John J Krais, Mohamad Cherry, et al.
Journal of Nanoscience and Nanotechnology
|
October 28, 2015
Optical and Magnetic Properties of ZnO Nanoparticles Doped with Co, Ni and Mn and Synthesized at Low Temperature
Jared M Hancock, William M Rankin, Talaat M Hammad, et al.
Biophysical Journal
|
November 28, 2020
Mechanism and Kinetics of Copper Complexes Binding to the Influenza A M2 S31N and S31N/G34E Channels
Kelly L McGuire, Phillip Smit, Daniel H Ess, et al.
Anticancer Research
|
July 11, 2006
Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration
Xiao-Ping Zang, Naveen R Palwai, Megan R Lerner, et al.
Nanotechnology
|
August 27, 2013
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy
Luís F F Neves, John J Krais, Brent D Van Rite, et al.
Molecular Biomedicine
|
February 18, 2024
Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, et al.
Blood
|
October 1, 2005
A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties
Xin Huang, Wei-Qun Ding, Joshua L Vaught, et al.
Molecular Biomedicine
|
April 2, 2024
Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer
Alexis Woodward, Benjamin Southard, Sampurna Chakraborty, et al.
Molecular Cancer Therapeutics
|
May 20, 2017
Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide
John J Krais, Needa Virani, Patrick H McKernan, et al.
Page
of 7